-
Je něco špatně v tomto záznamu ?
PAR2: The Cornerstone of Pancreatic Diseases
P. Suhaj, T. Olejar, R. Matej
Jazyk angličtina Země Česko
Typ dokumentu přehledy, časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
PubMed Central
od 2020
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- lidé MeSH
- nemoci slinivky břišní * diagnóza MeSH
- pankreas metabolismus MeSH
- receptor PAR-2 * metabolismus MeSH
- receptory spřažené s G-proteiny MeSH
- trypsin metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
It has been 30 years since the first member of the protease-activated receptor (PAR) family was discovered. This was followed by the discovery of three other receptors, including PAR2. PAR2 is a G protein-coupled receptor activated by trypsin site-specific proteolysis. The process starts with serine proteases acting between arginine and serine, creating an N-terminus that functions as a tethered ligand that binds, after a conformational change, to the second extracellular loop of the receptor, leading to activation of G-proteins. The physiological and pathological functions of this ubiquitous receptor are still elusive. This review focuses on PAR2 activation and its distribution under physiological and pathological conditions, with a particular focus on the pancreas, a significant producer of trypsin, which is the prototype activator of the receptor. The role in acute or chronic pancreatitis, pancreatic cancer, and diabetes mellitus will be highlighted.
3rd Faculty of Medicine Charles University Prague Czech Republic
Department of Pathology and Molecular Medicine Thomayer University Hospital Prague Czech Republic
Department of Pathology University Hospital Kralovske Vinohrady Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22029552
- 003
- CZ-PrNML
- 005
- 20230518085923.0
- 007
- ta
- 008
- 230113s2022 xr a f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934931 $2 doi
- 035 __
- $a (PubMed)36073735
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Šuhaj, Petr $u Department of Pathology and Molecular Medicine, Third Medical Faculty, Charles University and Thomayer University Hospital, Prague, Czech Republic $7 xx0262672 $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 245 10
- $a PAR2: The Cornerstone of Pancreatic Diseases / $c P. Suhaj, T. Olejar, R. Matej
- 520 9_
- $a It has been 30 years since the first member of the protease-activated receptor (PAR) family was discovered. This was followed by the discovery of three other receptors, including PAR2. PAR2 is a G protein-coupled receptor activated by trypsin site-specific proteolysis. The process starts with serine proteases acting between arginine and serine, creating an N-terminus that functions as a tethered ligand that binds, after a conformational change, to the second extracellular loop of the receptor, leading to activation of G-proteins. The physiological and pathological functions of this ubiquitous receptor are still elusive. This review focuses on PAR2 activation and its distribution under physiological and pathological conditions, with a particular focus on the pancreas, a significant producer of trypsin, which is the prototype activator of the receptor. The role in acute or chronic pancreatitis, pancreatic cancer, and diabetes mellitus will be highlighted.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a trypsin $x metabolismus $7 D014357
- 650 12
- $a receptor PAR-2 $x metabolismus $7 D044464
- 650 _2
- $a receptory spřažené s G-proteiny $7 D043562
- 650 12
- $a nemoci slinivky břišní $x diagnóza $7 D010182
- 650 _2
- $a pankreas $x metabolismus $7 D010179
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Olejár, Tomáš $7 xx0242541 $u Department of Pathology and Molecular Medicine, Thomayer University Hospital, Prague, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Matěj, Radoslav, $d 1974- $7 xx0103860 $u Department of Pathology and Molecular Medicine, Thomayer University Hospital, Prague, Czech Republic $u Department of Pathology, University Hospital Kralovske Vinohrady, Prague, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 71, č. 5 (2022), s. 583-596
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36073735 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20230113 $b ABA008
- 991 __
- $a 20230518085917 $b ABA008
- 999 __
- $a ok $b bmc $g 1894747 $s 1180877
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 71 $c 5 $d 583-596 $e 20220908 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK198 $a Pubmed-20230113